Kyleena 19.5 mg
Kyleena 19.5 mg is a medicine authorised by Swissmedic under authorisation number 66148. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 February 2017 and the authorisation is valid without a time limit. ATC code G02BA03 places the medicine in the group Other gynecologicals.
| Authorisation number | 66148 |
|---|---|
| Name | Kyleena 19.5 mg |
| Full name | Kyleena 19.5 mg, Intrauterines Wirkstofffreisetzungssystem |
| Authorisation holder | Bayer (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G02BA03 |
| First authorisation | 16 February 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Kyleena 19.5 mg, Intrauterines Wirkstofffreisetzungssystem | B | 16 February 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Stück | G02BA03 | 09.02.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Kyleena 19.5 mg authorised in Switzerland?
Yes. Kyleena 19.5 mg is authorised by Swissmedic under authorisation number 66148, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Kyleena 19.5 mg have?
Kyleena 19.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Kyleena 19.5 mg?
The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.